HealthEquity, Inc. $HQY Shares Sold by Faithward Advisors LLC

Faithward Advisors LLC lowered its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,374 shares of the company’s stock after selling 10,206 shares during the period. Faithward Advisors LLC’s holdings in HealthEquity were worth $3,332,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in HQY. Xponance Inc. boosted its position in shares of HealthEquity by 0.8% during the 3rd quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after purchasing an additional 102 shares during the period. Truist Financial Corp boosted its position in shares of HealthEquity by 4.9% during the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after purchasing an additional 119 shares during the period. Fiduciary Trust Co boosted its position in shares of HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after purchasing an additional 120 shares during the period. Larson Financial Group LLC boosted its position in shares of HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares during the period. Finally, GAMMA Investing LLC boosted its position in shares of HealthEquity by 9.5% during the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock worth $178,000 after purchasing an additional 168 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $86.97 on Tuesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $106.60. The stock has a market cap of $7.27 billion, a P/E ratio of 32.57, a price-to-earnings-growth ratio of 1.49 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a fifty day simple moving average of $84.69 and a 200-day simple moving average of $85.62.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Analyst Ratings Changes

HQY has been the subject of several recent research reports. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research report on Monday, June 1st. JPMorgan Chase & Co. decreased their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. Raymond James Financial set a $100.00 price target on shares of HealthEquity in a research report on Tuesday, February 17th. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Finally, Citizens Jmp raised their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $110.57.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,081 shares of company stock valued at $1,193,000 over the last ninety days. Insiders own 1.60% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.